Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763295 · ClinicalTrials.gov registry record
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 53
- Enrollment target
NCT00763295 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 53 participants.
The verdict
NCT00763295 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless of age. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. Therefore, an accurate and reliable method for detection of latent tuberculosis in patients with HIV is urgently needed. This prospective study will examine the utility of interferon-gamma (IFN-γ) based assay, T-SPOT.TB,for detection of TB in HIV-infected individuals.
Interventions
- OTHER T-Spot.TB test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00763295
The ClinicalTrials.gov registry entry for NCT00763295 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T-Spot.TB test is the first listed.
NCT00763295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00763295 about?
NCT00763295 is a clinical study titled "Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?". HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless of age. Sensitivity of the PPD testing is, however, dependent on a normal T cell function. Therefore, an accurate ...
What is the current status of trial NCT00763295?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2008-05. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00763295?
The interventions under investigation include: T-Spot.TB test (OTHER).
Who is sponsoring clinical trial NCT00763295?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.